RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 88 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,170,658 | +111.7% | 806,622 | +106.7% | 0.00% | – |
| Q2 2023 | $2,915,011 | +68.5% | 390,229 | +50.5% | 0.00% | – |
| Q1 2023 | $1,729,978 | -32.7% | 259,367 | -22.2% | 0.00% | – |
| Q4 2022 | $2,568,748 | -12.5% | 333,171 | +20.7% | 0.00% | – |
| Q3 2022 | $2,937,000 | +62.7% | 275,942 | +24.5% | 0.00% | – |
| Q2 2022 | $1,805,000 | +79.2% | 221,704 | +57.7% | 0.00% | – |
| Q1 2022 | $1,007,000 | -49.1% | 140,597 | +21.7% | 0.00% | – |
| Q4 2021 | $1,978,000 | +787.0% | 115,501 | +1090.7% | 0.00% | – |
| Q3 2021 | $223,000 | +443.9% | 9,700 | +753.9% | 0.00% | – |
| Q2 2021 | $41,000 | – | 1,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |